Skip to main content
Equibles

UBS Group AG

Position in TENX — Tenax Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to TENX Full portfolio

Position in TENX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,427,979
-$4,670,908 QoQ
Shares Held
98,143
-74.3% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 111 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TENX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. TENX ranks #240 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in TENX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,427,979 98,143
2026-03-31 $6,098,887 381,419
2025-12-31 $8,239 676
2025-09-30 $904 119
2025-06-30 $79 14
2025-03-31 $18,948 2,893
2024-12-31 $18 3
2024-09-30 $2,380 688
2024-06-30 $4,519 1,499
2024-03-31 $5,867 1,384